Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Irrigation in Breast Reconstruction
NCT03213249Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2017
- Primary completion
- Sep 2018
- Modality
- Reversible Covalent Inhibitors, Nanoparticles, Transdermal Patches
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cefazolin, gentamicin and bacitracin in breast implant infection (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Number of tissue expanders removed due to infection at 1 year and Number of tissue expanders removed due to patient preference at 1 year. Started Jul 2017; status: completed.
02
Drugs
cefazolingentamicinbacitracin
03
Conditions
breast implant infection
Beyond the preview
Go deeper on NCT03213249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03213249.